These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2688102)

  • 1. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
    Talbot M
    Semin Thromb Hemost; 1989 Jul; 15(3):293-301. PubMed ID: 2688102
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
    Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombin effects of native and recombinant hirudins.
    Markwardt F; Stürzebecher J; Glusa E
    Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

  • 5. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
    Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hirudin and hirudin fragments].
    Deschamps A; Samama M
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
    Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hirudin--comeback of Hirudo medicinalis].
    Lassila R
    Duodecim; 1992; 108(6):535-7. PubMed ID: 1366111
    [No Abstract]   [Full Text] [Related]  

  • 10. Production and evaluation of recombinant hirudin.
    Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
    Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
    Lu WF; Mo W; Liu Z; Fu WG; Guo DQ; Wang YQ; Song HY
    Thromb Res; 2010 Oct; 126(4):e339-43. PubMed ID: 20483158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comeback of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor.
    Maraganore JM
    Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339
    [No Abstract]   [Full Text] [Related]  

  • 16. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirudins: from leeches to man.
    Wallis RB
    Semin Thromb Hemost; 1996; 22(2):185-96. PubMed ID: 8807716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin inhibition and coronary artery thrombolysis.
    Yao SK; McNatt JM; Anderson HV; Eidt JF; Cui KX; Golino P; Glas-Greenwalt P; Maraganore JM; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1990; 103():1-9. PubMed ID: 2132522
    [No Abstract]   [Full Text] [Related]  

  • 20. Hirudin and derivatives as anticoagulant agents.
    Markwardt F
    Thromb Haemost; 1991 Jul; 66(1):141-52. PubMed ID: 1926044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.